יום שבת, כ״ג אלול תשפ״וSaturday, September 5, 2026
Follow Us
The effectiveness of these drugs in patients with generalized viral diseases and COVID-19, in particular, can be relatively quickly examined and made more readily available.
A new Israeli treatment for Gaucher disease, approved by the FDA, has received a green light in Canada as well.
September 4, 2026 
